Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced data published in Open Forum Infectious Diseases shows earlier use of comprehensive ...

How do immune cells strike a balance, unleashing rapid attacks against pathogens or cancer, while avoiding damage to healthy ...

By targeting proteins used to splice genes, UC San Diego researchers have unlocked a new approach to treating triple-negative ...

A single enzyme that can generate all four nucleoside triphosphates, the building blocks of ribonucleic acid (RNA), has been ...

Your sperm may age faster than you think—researchers uncovered a molecular clock that could affect your child’s health before ...

The cancer gene MYC camouflages tumours by suppressing alarm signals that normally activate the immune system. This finding from a new study offers a ...

Could this mark a shift in how we think about cancer therapy? At least in the laboratory, evidence suggests it may be.

The company plans to begin enrolling the trial next quarter across eight US sites to test the vaccine as a monotherapy and in combination with Keytruda.

The cancer gene MYC camouflages tumours by suppressing alarm signals that normally activate the immune system. This finding ...

An international team of scientists has designed a new type of therapy to target the mutant toxic RNA that causes myotonic ...